Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up

BMC Cancer

Research Article

Kashif Shafique¹  Carole Hart¹  Khaver Qureshi²  Hing Leung³  David S Morrison⁴  Philip McLoone⁴ 

[1] Institute of Health & Wellbeing, Public Health, University of Glasgow, 1 Lilybank Gardens, G12 8RZ, Glasgow, UK;Urology Department, Gartnavel General Hospital, 1053 Great Western Road, G12 0YN, Glasgow, UK;Urology Department, Gartnavel General Hospital, 1053 Great Western Road, G12 0YN, Glasgow, UK;Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, G61 1BD, Bearsden, Glasgow, UK;West of Scotland Cancer Surveillance Unit, University of Glasgow, 1 Lilybank Gardens, G12 8RZ, Glasgow, UK;

关键词: Cholesterol;    Prostate cancer;    Incidence;    Gleason grade;   

DOI  :  10.1186/1471-2407-12-25

 received in 2011-09-01, accepted in 2012-01-19,  发布年份 2012

来源: Springer

【 摘 要 】

BackgroundHigh cholesterol may be a modifiable risk factor for prostate cancer but results have been inconsistent and subject to potential "reverse causality" where undetected disease modifies cholesterol prior to diagnosis.MethodsWe conducted a prospective cohort study of 12,926 men who were enrolled in the Midspan studies between 1970 and 1976 and followed up to 31st December 2007. We used Cox-Proportional Hazards Models to evaluate the association between baseline plasma cholesterol and Gleason grade-specific prostate cancer incidence. We excluded cancers detected within at least 5 years of cholesterol assay.Results650 men developed prostate cancer in up to 37 years' follow-up. Baseline plasma cholesterol was positively associated with hazard of high grade (Gleason score≥8) prostate cancer incidence (n = 119). The association was greatest among men in the 2nd highest quintile for cholesterol, 6.1 to < 6.69 mmol/l, Hazard Ratio 2.28, 95% CI 1.27 to 4.10, compared with the baseline of < 5.05 mmol/l. This association remained significant after adjustment for body mass index, smoking and socioeconomic status.ConclusionsMen with higher cholesterol are at greater risk of developing high-grade prostate cancer but not overall risk of prostate cancer. Interventions to minimise metabolic risk factors may have a role in reducing incidence of aggressive prostate cancer.

【 授权许可】

CC BY   
© Shafique et al; licensee BioMed Central Ltd. 2012